New Jersey
CNS clinical trials in New Jersey
80 CNS studies are recruiting participants at sites in 43 cities across New Jersey as of November 16, 2026, according to ClinicalTrials.gov.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Every New Jersey city with a recruiting study
By research area: Depression (20), Schizophrenia (15), Multiple Sclerosis (14), Epilepsy (10), Migraine (9), Parkinson's Disease (6), ADHD (3), Bipolar Disorder (3).
Marlton (17), Hackensack (12), Toms River (10), Neptune City (6), New Brunswick (6), Cherry Hill (5), Livingston (4), Morristown (4), Teaneck (4), Basking Ridge (3), East Hanover (3), Middletown (3), Montvale (3), Paramus (3), Camden (2), Irvington (2), Marlboro (2), Newark (2), Belle Mead (1), Berlin (1), Brick (1), Bridgewater (1), Cape May Court House (1), Edison (1), Egg Harbor (1), Flemington (1), Freehold (1), Hackettstown (1), Holmdel (1), Lawrenceville (1), Manahawkin (1), Moorestown (1), Newton (1), Piscataway (1), Plainsboro (1), Pompton (1), Princeton (1), Red Bank (1), Ridgewood (1), Summit (1), West Long Branch (1), West Orange (1), Woodbridge (1).
The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.
Depression: recently updated in New Jersey
Basic details from each study's public record (the 12 most recently updated of 80). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
Double-blind, Placebo-controlled Study in Adults With Major Depressive Disorder
- Phase 2
- Ages 18 to 70
- All sexes
- Sponsor
- Supernus Pharmaceuticals, Inc.
- Recruiting in
- Marlton
- Registry record
- NCT07226661 · updated
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
- Phase 3
- Ages 18 to 85
- All sexes
- Sponsor
- Cybin IRL Limited
- Recruiting in
- Toms River
- Registry record
- NCT06793397 · updated
Source: ClinicalTrials.gov. Data processed . See every depression study recruiting in New Jersey on ClinicalTrials.gov.
Schizophrenia: recently updated in New Jersey
Study to Evaluate Efficacy and Safety of Roluperidone in Adult Subjects With Negative Symptoms and Stable Positive Symptoms of Schizophrenia and to Evaluate the Relapse Rate of Roluperidone and Antipsychotic Medications
- Phase 3
- Ages 18 to 55
- All sexes
- Sponsor
- Minerva Neurosciences
- Recruiting in
- Marlton
- Registry record
- NCT07565428 · updated
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
- Phase 2
- Ages 55 to 90
- All sexes
- Sponsor
- MapLight Therapeutics
- Recruiting in
- West Long Branch
- Registry record
- NCT06887192 · updated
Source: ClinicalTrials.gov. Data processed . See every schizophrenia study recruiting in New Jersey on ClinicalTrials.gov.
Bipolar disorder: recently updated in New Jersey
A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-2)
- Phase 3
- Ages 18 to 65
- All sexes
- Sponsor
- Bristol-Myers Squibb
- Recruiting in
- Marlton
- Registry record
- NCT06951711 · updated
Source: ClinicalTrials.gov. Data processed . See every bipolar disorder study recruiting in New Jersey on ClinicalTrials.gov.
Parkinson's disease: recently updated in New Jersey
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
- Phase 3
- Ages 18 and older
- Female participants
- Sponsor
- AstraZeneca
- Recruiting in
- Hackensack
- Registry record
- NCT06989112 · updated
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Recruiting in
- Hackensack
- Registry record
- NCT06841354 · updated
Source: ClinicalTrials.gov. Data processed . See every Parkinson's disease study recruiting in New Jersey on ClinicalTrials.gov.
Multiple sclerosis (MS): recently updated in New Jersey
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Recruiting in
- New Brunswick
- Registry record
- NCT03816345 · updated
Source: ClinicalTrials.gov. Data processed . See every multiple sclerosis study recruiting in New Jersey on ClinicalTrials.gov.
Epilepsy: recently updated in New Jersey
Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1
- Phase 3
- Ages 18 to 75
- All sexes
- Sponsor
- Rapport Therapeutics Inc.
- Recruiting in
- Hackensack · Livingston
- Registry record
- NCT07563881 · updated
Source: ClinicalTrials.gov. Data processed . See every epilepsy study recruiting in New Jersey on ClinicalTrials.gov.
Migraine: recently updated in New Jersey
Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
- Phase 4
- Ages 18 to 70
- All sexes
- Sponsor
- Mayo Clinic
- Recruiting in
- Edison
- Registry record
- NCT06972056 · updated
Study of EVO756 in Adults With Migraine
- Phase 2
- Ages 18 to 64
- All sexes
- Sponsor
- Evommune, Inc.
- Recruiting in
- Toms River
- Registry record
- NCT07616128 · updated
A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- Phase 3
- Ages 18 to 75
- All sexes
- Sponsor
- TriGemX Bio, Inc.
- Recruiting in
- Toms River
- Registry record
- NCT07816367 · updated
Source: ClinicalTrials.gov. Data processed . See every migraine study recruiting in New Jersey on ClinicalTrials.gov.
Ask about studies in New Jersey
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.
CNS Clinical Research does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections